Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK

Matthew J Carr; Alison K Wright; Lalantha Leelarathna; Hood Thabit; Nicola Milne; Naresh Kanumilli; Darren M Ashcroft; Martin K Rutter

doi:10.1016/S2213-8587(21)00116-9

Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK

Lancet Diabetes Endocrinol. 2021 Jul;9(7):413-415. doi: 10.1016/S2213-8587(21)00116-9. Epub 2021 May 11.

Authors

Matthew J Carr¹, Alison K Wright², Lalantha Leelarathna³, Hood Thabit³, Nicola Milne⁴, Naresh Kanumilli⁴, Darren M Ashcroft⁵, Martin K Rutter³

Affiliations

¹ Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK. Electronic address: matthew.carr@manchester.ac.uk.
² Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK.
³ Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK.
⁴ Manchester Academic Health Science Centre, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK.
⁵ Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK.

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Adult
Aged
COVID-19*
Cohort Studies
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / mortality*
Diabetes Mellitus, Type 2 / therapy
Female
Humans
Incidence
Male
Middle Aged
United Kingdom / epidemiology